Please use this identifier to cite or link to this item: http://repository.pdmu.edu.ua/handle/123456789/19161
Title: Morphological manifestations of side effects caused by the radiocontrast agent tomohexol in the form of type i hypersensitivity reaction in a patient with arteriosclerosis obliterans of the lower extremities (case report)
Authors: Twum, C.
Borysenko, V.
Adeyemi, O.O.
Okoye, G.G.
Supervisor: Sovgyrya, S. M.
Zadvornova, A. P.
Совгиря, Світлана Миколаївна
Задворнова, Анна Петрівна
Issue Date: 2022
Publisher: Полтавський державний медичний університет
Citation: Morphological manifestations of side effects caused by the radiocontrast agent tomohexol in the form of type i hypersensitivity reaction in a patient with arteriosclerosis obliterans of the lower extremities (case report) / C. Twum, V. Borysenko, O. O. Adeyemi, G. G. Okoye ; науковий керівник : S. M. Sovgyrya, A. P. Zadvornova // IMEDSCOP 2022 : abstract book of 3rd International Medical Students Conference in Poltava of Poltava State Medical University, Poltava, 6-th of October 2022. – Poltava, 2022. – P. 122–123.
Abstract: Today radiocontrast agents are widely used for their ability to contrast and visualise the vascular bed in most human tissues and organs. The agents can be grouped according to their chemical structure into monomers and dimers, as well as ionic and non-ionic compounds. The active agent in Tomohexol 350 is iohexol – a non-ionic monomeric iodinated and water soluble radiocontrast agent. Hypersensitivity reactions are rare with the use of these type of compounds, however they can in some instances cause anaphylactic shock.
Keywords: anaphylactic shock
Tomohexol
mast cell degranulation
tryptase
drug side effects
URI: http://repository.pdmu.edu.ua/handle/123456789/19161
Appears in Collections:Наукові праці. Кафедра патологічної анатомії та судової медицини

Files in This Item:
File Description SizeFormat 
Effects_caused_by_the_radiocontrast_agent.pdf266,77 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.